Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ONWARD Medical logo — Empowering Movement

ONWARD Medical

Empowering Movement

Founded 2014 The Netherlands The Netherlands 208 employees Post-IPO Debt Total: $136.47M Biotechnology, Health Care +3

General Information

Company Name ONWARD Medical
Founded Year 2014
Location The Netherlands The Netherlands
Employees 208
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with ONWARD Medical. To contact ONWARD Medical, visit onwd.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ONWARD Medical compare?

A PDF of ONWARD Medical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ONWARD Medical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ONWARD Medical

Onward is a medical technology startup with a mission to restore movement, function, and independence in individuals with spinal cord injuries. The company's innovative ARC Therapy, offered through implantable (ARC-IM) or external (ARC-EX) systems, delivers targeted spinal cord stimulation to enhance movement and other functions, aiming to improve the quality of life for those with spinal cord injuries. Notably, Onward Medical has received nine Breakthrough Device Designations from the U.S. FDA for both ARC-IM and ARC-EX. The company reported positive top-line data from its pivotal study, Up-LIFT, assessing the efficacy of transcutaneous ARC Therapy to enhance upper extremity strength and function. Onward Medical has completed its first-in-human use of the ARC-IM neurostimulator and is now preparing marketing approval submissions for the U.S. and Europe. Founded in 2014, Onward Medical is based in Eindhoven, the Netherlands, with a Science and Engineering Center located in Lausanne, Switzerland, and a growing presence in the U.S. in Boston, Massachusetts. The company has a notable academic partnership with .NeuroRestore, a collaboration between the Swiss Federal Institute of Technology (EPFL) and Lausanne University Hospital (CHUV). In March 2024, Onward Medical secured a significant €20.00MPost-IPO Equity investment. The investors involved in this funding round include Life Science Partners, Inkef, Grégoire Courtine, Kristina Dziekan, Fred Colen, Lorenzo Fanti, Robert O'Dell, Ian Curtis, Dave Marver, and Jocelyne Bloch. This recent investment demonstrates the confidence that prominent industry professionals and investment firms place in Onward Medical's innovative technologies and its potential to make a meaningful impact in the biotechnology and healthcare industries.

Business keywords: spinal cord injuries, neuroscience, spinal cord stimulation, FDA Breakthrough Device Designations, implantable technology, external stimulation, pivotal study, transcutaneous therapy, neurostimulator, academic partnership, rehabilitation, neurological disorders, real-time motion feedback, training tools

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt €52.50M 1
Runway Growth Capital
Runway Growth Capital
28 Jun 2024
Post IPO Equity €20.00M 10
GIMV Wellington Partners Invest-NL
GIMV, Wellington Partners +8
20 Mar 2024
Grant €1.20M 1
European Innovation Council
European Innovation Council
16 Jun 2022
Venture Round €26.54M 6
GIMV Wellington Partners Invest-NL
GIMV, Wellington Partners +4
22 Apr 2021
Grant Undisclosed 1
Eurostars
19 Mar 2019
Debt Financing €10.00M 1
Netherlands Enterprise Agency
Netherlands Enterprise Agency
19 Apr 2016
Series A €26.00M 4
GIMV Wellington Partners Inkef
GIMV, Wellington Partners +2
19 Apr 2016
Grant Undisclosed 1
MassChallenge
MassChallenge
01 Nov 2014
Grant €100.00K -
22 Apr 2014
Grant Fr.20.00K 1
Venture Kick
Venture Kick
05 Feb 2014

View All 12 Funding Rounds

ONWARD Medical Alternatives & Competitors

ONWARD Medical vs
Ulevo Health
Ulevo Health

Lightweight, personalized devices designed to detect and reduce muscle spasms linked to neurological...

Pre-Seed
Health Care, Medical Devices
Compare ONWARD Medical vs Ulevo Health

FAQ About ONWARD Medical

Empowering Movement
ONWARD Medical was founded in 2014.
ONWARD Medical is headquartered in The Netherlands.
ONWARD Medical operates in Biotechnology, Health Care, Health and Wellness, Manufacturing and Medical Devices. Its work centres on spinal cord injuries, neuroscience, spinal cord stimulation and FDA Breakthrough Device Designations.
ONWARD Medical has approximately 208 employees.
ONWARD Medical has completed 12 funding rounds, raising a total of $136.47M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to ONWARD Medical include Ulevo Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ONWARD Medical and Ulevo Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ONWARD Medical, https://bouncewatch.com/company/onward-2, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout